@article{article, title  = {{Radium-223 dichloride (Ra-223) efficacy and safety in patients with castration-resistant prostate cancer (CRPC) with bone metastases: Phase 3 ALSYMPCA study findings stratified by age group}},

 url = {{}},

 year = {{2014}},

 month = {{10}},

 author = {{Wedel S and Wiechno P and Helle SI and Logue J and Nilsson S and Sartor O and Coleman RE and Kliment J and Fang F and Parker C}},

 volume = {{37}},

 journal = {{ONCOLOGY RESEARCH AND TREATMENT}},

 pages = {{86-87}},

 note = {{Accessed on 2025/10/10}}}